ClearPoint Neuro (CLPT) Cash from Investing Activities (QoQ) (2011 - 2026)
ClearPoint Neuro (CLPT) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 398.59 Mn | 362.99 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -159.28% |
| Dec 31, 2025 | 646.73% |
| Sep 30, 2025 | -118.68% |
| Jun 30, 2025 | 50.27% |
| Mar 31, 2025 | 30.42% |
| Dec 31, 2024 | -2,091.67% |
| Dec 31, 2023 | 20.00% |
| Sep 30, 2023 | -102.47% |
| Jun 30, 2023 | 6,991.30% |
| Mar 31, 2023 | -101.17% |
| Dec 31, 2022 | 1,961.49% |
| Sep 30, 2022 | 97.09% |
| Jun 30, 2022 | -11,611.35% |
| Mar 31, 2022 | -386.84% |
| Dec 31, 2021 | 69.60% |
| Sep 30, 2021 | -457.14% |
| Jun 30, 2021 | 187.50% |
| Mar 31, 2021 | 2.44% |
| Mar 31, 2020 | -232,205.26% |
| Dec 31, 2019 | 101.86% |